Carisma Therapeutics News

Carisma Therapeutics | 8-K: Current report

Oct 31 04:34

Carisma Therapeutics | 8-K: Current report

Oct 12 04:54

Carisma Therapeutics | 8-K: Current report

Jul 9 19:35

Carisma Therapeutics | 8-K: Current report

Jul 3 04:39

Carisma Therapeutics | 8-K: Current report

Jul 1 19:38

Carisma Therapeutics | 8-K: Current report

Jun 28 04:43

Carisma Therapeutics | 8-K: Current report

Jun 15 04:38

Carisma Therapeutics | 8-K: Current report

Jun 15 04:36

Carisma Therapeutics | DEF 14A: Definitive information statements

Apr 29 20:07

Carisma Therapeutics | 8-K: Current report

Apr 10 20:02

Carisma Therapeutics | 8-K: Current report

Sep 1, 2023 21:05

Carisma Therapeutics | 8-K: Current report

Jun 10, 2023 04:17

Carisma Therapeutics | 8-K: Current report

May 13, 2023 05:05

Carisma Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

May 13, 2023 04:56

Carisma Therapeutics | DEF 14A: Definitive proxy statements

Apr 28, 2023 19:30

Carisma Therapeutics | PRE 14A: Preliminary proxy statement not related to a contested matter or merger/acquisition

Apr 18, 2023 05:17

Carisma Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Apr 18, 2023 05:14

Carisma Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Apr 18, 2023 05:11

Carisma Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Apr 4, 2023 20:53

Carisma Therapeutics | 8-K/A: Current report (Amendment)

Apr 4, 2023 20:40